IL94228A - A method for isolating and purifying transpirin receptor proteins from bacteria and vaccines containing them - Google Patents

A method for isolating and purifying transpirin receptor proteins from bacteria and vaccines containing them

Info

Publication number
IL94228A
IL94228A IL9422890A IL9422890A IL94228A IL 94228 A IL94228 A IL 94228A IL 9422890 A IL9422890 A IL 9422890A IL 9422890 A IL9422890 A IL 9422890A IL 94228 A IL94228 A IL 94228A
Authority
IL
Israel
Prior art keywords
transferrin
transferrin receptor
vaccine
haemophilus
receptor
Prior art date
Application number
IL9422890A
Other languages
English (en)
Hebrew (he)
Other versions
IL94228A0 (en
Original Assignee
Univ Technologies Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Technologies Int filed Critical Univ Technologies Int
Publication of IL94228A0 publication Critical patent/IL94228A0/xx
Publication of IL94228A publication Critical patent/IL94228A/en
Priority to IL14497301A priority Critical patent/IL144973A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL9422890A 1989-04-27 1990-04-27 A method for isolating and purifying transpirin receptor proteins from bacteria and vaccines containing them IL94228A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL14497301A IL144973A0 (en) 1989-04-27 2001-08-19 A vaccine which provides protective immunity against a bacterial pathogen

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34435689A 1989-04-27 1989-04-27
US07/507,481 US5292869A (en) 1989-04-27 1990-04-09 Method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same

Publications (2)

Publication Number Publication Date
IL94228A0 IL94228A0 (en) 1991-01-31
IL94228A true IL94228A (en) 2001-03-19

Family

ID=26993881

Family Applications (2)

Application Number Title Priority Date Filing Date
IL9422890A IL94228A (en) 1989-04-27 1990-04-27 A method for isolating and purifying transpirin receptor proteins from bacteria and vaccines containing them
IL14497301A IL144973A0 (en) 1989-04-27 2001-08-19 A vaccine which provides protective immunity against a bacterial pathogen

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL14497301A IL144973A0 (en) 1989-04-27 2001-08-19 A vaccine which provides protective immunity against a bacterial pathogen

Country Status (12)

Country Link
US (1) US5292869A (fr)
EP (1) EP0528787B1 (fr)
KR (1) KR100240974B1 (fr)
AT (1) ATE173935T1 (fr)
AU (1) AU649950B2 (fr)
CA (1) CA2051808C (fr)
DE (1) DE69032806T2 (fr)
DK (1) DK0528787T3 (fr)
ES (1) ES2127184T3 (fr)
IL (2) IL94228A (fr)
NZ (2) NZ247967A (fr)
WO (1) WO1990012591A1 (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1378245T3 (da) * 1990-08-23 2009-10-26 Univ North Carolina Transferrin-bindende-proteiner fra neisseria gonorrhoeae og neisseria meningitidis. Deres anvendelse i en vaccine
FR2682041B1 (fr) * 1991-10-03 1994-01-14 Pasteur Merieux Serums Vaccins Vaccin contre les infections a neisseria meningitidis.
FR2682114B1 (fr) * 1991-10-03 1996-02-23 Pasteur Merieux Serums Vacc Vaccin de sous-unite contre les infections a neisseria meningitidis et sous-unites correspondantes a l'etat purifie.
US5417971A (en) * 1991-10-22 1995-05-23 University Of Saskatchewan Vaccines for Actinobacillus pleuropneumoniae
FR2692592B1 (fr) * 1992-06-19 1995-03-31 Pasteur Merieux Serums Vacc Fragments d'ADN codant pour les sous-unités du récepteur de la transferrine de Neisseria meningitidis et procédés les exprimant.
US5534256A (en) * 1992-07-02 1996-07-09 University Of Saskatchewan Haemophilus somnus outer membrane protein extract enriched with iron-regulated proteins
WO1994005783A1 (fr) * 1992-09-07 1994-03-17 Bioproperties (Australia) Pty. Limited Nouvel organisme du genre haemophilis et vaccins le contenant
CA2182976C (fr) * 1994-02-09 2011-07-12 Daryll A. Emery Immunisation active au moyen d'un recepteur proteique de siderophore
US5830479A (en) * 1994-02-09 1998-11-03 Willmar Poultry Company, Inc. Active immunization using a siderophore receptor protein
US6121427A (en) * 1994-10-24 2000-09-19 Connaught Laboratories Limited Major outer membrane protein CD of branhamella
US6440425B1 (en) * 1995-05-01 2002-08-27 Aventis Pasteur Limited High molecular weight major outer membrane protein of moraxella
US5817789A (en) 1995-06-06 1998-10-06 Transkaryotic Therapies, Inc. Chimeric proteins for use in transport of a selected substance into cells
US6290970B1 (en) 1995-10-11 2001-09-18 Aventis Pasteur Limited Transferrin receptor protein of Moraxella
US6048539A (en) * 1995-11-02 2000-04-11 Connaught Laboratories Limited Lactoferrin receptor protein
EP0863986A1 (fr) * 1995-12-01 1998-09-16 Reggie Y. C. Lo Proteines de pasteurella haemolytica liant la transferine, et vaccins contenant ces proteines
US6610506B1 (en) 1995-12-01 2003-08-26 University Technologies International, Inc. Transferrin binding proteins of Pasteurella haemolytica and vaccines containing same
US6440701B1 (en) 1996-03-08 2002-08-27 Aventis Pasteur Limited Transferrin receptor genes of Moraxella
US6090576A (en) * 1996-03-08 2000-07-18 Connaught Laboratories Limited DNA encoding a transferrin receptor of Moraxella
DK1005487T3 (da) * 1997-01-31 2006-11-13 Wyeth Corp Ydre 74 kD-membranprotein fra Moraxella catarrhalis
JP2001502925A (ja) * 1997-06-03 2001-03-06 コノート ラボラトリーズ リミテッド モラクセラのラクトフェリン受容体遺伝子
US5977337A (en) * 1997-06-03 1999-11-02 Connaught Laboratories Limited Lactoferrin receptor genes of Moraxella
FR2767060B1 (fr) * 1997-08-07 2000-02-11 Pasteur Merieux Serums Vacc Vaccin meningocoque comportant la valence de souche bz83
GB9810084D0 (en) 1998-05-11 1998-07-08 Cortecs Uk Ltd Proteins
FR2785293B1 (fr) 1998-10-30 2002-07-05 Pasteur Merieux Serums Vacc Acides nucleiques et polypeptides specifiques des souches pathogenes du genre neisseria
US10967045B2 (en) 1998-11-02 2021-04-06 Secretary of State for Health and Social Care Multicomponent meningococcal vaccine
GB9823978D0 (en) * 1998-11-02 1998-12-30 Microbiological Res Authority Multicomponent meningococcal vaccine
US6391316B1 (en) * 1999-03-10 2002-05-21 University Of Saskatchewan Vaccine compositions comprising Haemophilus somnus transferrin-binding proteins and methods of use
US7241449B1 (en) 1999-04-12 2007-07-10 Aventis Pasteur Limited Transferrin receptor genes of moraxella
US6682754B2 (en) 1999-11-24 2004-01-27 Willmar Poultry Company, Inc. Ovo delivery of an immunogen containing implant
BR0206293B1 (pt) * 2001-01-03 2015-01-20 Epitopix Llc “composições compreendendo polipeptídeos receptores de sideróforos e porinas de micróbio gram-negativo, bem como métodos de isolar polipeptídeos de membrana externa
US8129504B2 (en) * 2001-08-30 2012-03-06 Biorexis Technology, Inc. Oral delivery of modified transferrin fusion proteins
US7759055B2 (en) * 2002-08-28 2010-07-20 Millipore Corporation Compositions of solution for sequencing reaction clean-up
ES2395022T3 (es) 2003-09-19 2013-02-07 Epitopix, Llc Polipéptidos de Campylobacter y sus métodos de uso
CA2597263C (fr) 2005-02-14 2017-01-17 Epitopix, Llc Polypeptides et compositions immunisantes contenant des polypeptides gram-positifs et methodes d'utilisation
US9932373B2 (en) 2009-03-23 2018-04-03 Epitopix, Llc Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
CN110251668A (zh) 2010-11-30 2019-09-20 霍夫曼-拉罗奇有限公司 低亲和力血脑屏障受体抗体及其用途
CN105980562A (zh) 2013-12-02 2016-09-28 A·B·施里维斯 源于细菌表面受体蛋白的免疫原性组合物和疫苗
US10166280B2 (en) 2016-06-08 2019-01-01 Epitopix, Llc Polypeptides and immunizing compositions containing Bacillus polypeptides and methods of use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2227861B1 (fr) * 1973-05-04 1976-07-02 Anvar
US4220638A (en) * 1978-10-12 1980-09-02 Merck & Co., Inc. Antigenic complex from N. Gonorrhoeae
US4271147A (en) * 1980-01-10 1981-06-02 Behringwerke Aktiengesellschaft Process for the isolation of membrane proteins from Neisseria meningitidis and vaccines containing same
US4447547A (en) * 1980-04-09 1984-05-08 University Patents, Inc. Immunoassay for measurement of reticulocytes, and immunoreactive reagents for use therein
US4434156A (en) * 1981-10-26 1984-02-28 The Salk Institute For Biological Studies Monoclonal antibodies specific for the human transferrin receptor glycoprotein
US4681761A (en) * 1985-10-24 1987-07-21 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Major iron-regulated protein of Neisseria gonorrhoeae and its use as vaccine
WO1989007140A1 (fr) * 1988-02-05 1989-08-10 Commonwealth Scientific And Industrial Research Or Systeme d'expression par genes (en particulier pour la proteine de rotavirus vp7) employant un peptide de signal etranger et eventuellement une sequence d'ancrage transmembrane
FR2644346B1 (fr) * 1989-03-20 1994-05-13 Rhone Merieux Vaccins contre les bacteries septicemiques, preparations d'antigenes de bacteries septicemiques, nouvelles bacteries et vecteurs pour la preparation de ces antigenes ou vaccins

Also Published As

Publication number Publication date
IL94228A0 (en) 1991-01-31
NZ233471A (en) 1993-11-25
ATE173935T1 (de) 1998-12-15
DE69032806T2 (de) 1999-08-05
US5292869A (en) 1994-03-08
AU649950B2 (en) 1994-06-09
AU5526190A (en) 1990-11-16
CA2051808C (fr) 1999-12-14
WO1990012591A1 (fr) 1990-11-01
DE69032806D1 (de) 1999-01-14
KR920700688A (ko) 1992-08-10
KR100240974B1 (ko) 2000-08-01
EP0528787A1 (fr) 1993-03-03
EP0528787B1 (fr) 1998-12-02
CA2051808A1 (fr) 1990-10-28
NZ247967A (en) 1995-02-24
ES2127184T3 (es) 1999-04-16
IL144973A0 (en) 2002-06-30
DK0528787T3 (da) 1999-08-16

Similar Documents

Publication Publication Date Title
EP0528787B1 (fr) Procede permettant d'isoler et de purifier des proteines receptrices de transferrine et de lactoferrine a partir de bacteries et preparation de vaccins contenant de telles proteines
US5141743A (en) Method for isolating and purifying transferrin and lactoferrin receptor proteins and vaccines containing the same
KR100242179B1 (ko) 디스크 드라이브 데이타경로 보전 제어구조
US6177085B1 (en) Generation of immune response using immunogenic conjugate of molecules
Danve et al. Transferrin-binding proteins isolated from Neisseria meningitidis elicit protective and bactericidal antibodies in laboratory animals
Frasch et al. Protection against group B meningococcal disease. III. Immunogenicity of serotype 2 vaccines and specificity of protection in a guinea pig model.
Gilleland Jr et al. Use of a purified outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine in mice
Munson et al. Purification and comparison of outer membrane protein P2 from Haemophilus influenzae type b isolates.
Une et al. Roles of V antigen in promoting virulence and immunity in yersiniae.
Verstreate et al. Outer membrane proteins of Brucella abortus: isolation and characterization
Cryz Jr et al. Protection against Pseudomonas aeruginosa infection in a murine burn wound sepsis model by passive transfer of antitoxin A, antielastase, and antilipopolysaccharide
US6558677B2 (en) Vaccine against gram negative bacteria
Banerjee-Bhatnagar et al. Expression of Neisseria meningitidis iron-regulated outer membrane proteins, including a 70-kilodalton transferrin receptor, and their potential for use as vaccines
Frasch Role of protein serotype antigens in protection against disease due to Neisseria meningitidis
JP2004189751A (ja) 非細胞性（Ａｃｅｌｌｕｌａｒ）百日咳ワクチン及びその調製方法
Craven et al. Protection against group B meningococcal disease: evaluation of serotype 2 protein vaccines in a mouse bacteremia model
CA1251396A (fr) Vaccins contenant des proteines ou des complexes peptidiques immunogenes
US4728639A (en) Type-specific opsonic antibodies evoked with a synthetic peptide of streptococcal M protein conjugated to polylysine without adjuvant
IL127163A (en) Vaccine which provides protective immunity against a bacterial pathogen
JP3335622B2 (ja) 細菌からトランスフェリン及びラクトフェリン受容体タンパク質を分離及び精製する方法並びにこれらを含有するワクチンを調製する方法
Beachey Type-specific opsonic antibodies evoked with a synthetic peptide of streptococcal M protein conjugated to polylysine without adjuvant
CN104096224B (zh) 一种增强流行性嗜血杆菌b型多糖蛋白结合物免疫原性的方法
AU662116B2 (en) Immunopotentiation of vaccines, particularly swine pleuropneumonia vaccines
LOEB et al. Evaluating vaccine candidates for the prevention of otitis media
Green et al. Overview: Bacterial Lipoproteins as Vaccines Candidates and Patent Considerations

Legal Events

Date Code Title Description
FF Patent granted
KB20 Patent renewed for 20 years
EXP Patent expired